Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue outlook after reporting first-quarter ...

Senseonics priced 8 million shares at $5.00 and 8 million pre-funded warrants at $4.999, with each warrant exercisable for a ...

Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.

Generated Q1 revenue of $11.7 million, an increase of 87% year-over-yearExpect full-year revenue in the range of $60M - $64M (previously $58M to ...

Detailed price information for Senseonics Holdings Inc (SENS-Q) from The Globe and Mail including charting and trades.

Q1 2026 earnings call recap: 85% revenue growth, raised 2026 guidance, margin outlook, DTC momentum, and key risks—read now.

Direct to Consumer (DTC) leads have doubled in Q4 compared to the pre-launch third quarter New patient shipments of approximately 600 in December were the highest monthly total in the Company’s ...

“We received FDA approval for Eversense 365 in the third quarter, and Mercy completed the first commercial patient insertion of our new sensor last month. This marks a significant achievement for ...

Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global ...

As of Wednesday, April 29, Senseonics Holdings, Inc.’s SENS share price has dipped by 5.98%, which has investors questioning ...

Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com. About Senseonics Senseonics Holdings, ...